Luba brings to Google pharmaceutical, biotechnology, and digital health industry experience and expertise in building and investing in innovative technology companies and providing strategic counsel to global corporations. Previously, Luba has served as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub for the Diagnostics Division. Luba is on the Board of MassBio and Brooklyn ImmunoTherapeutics, and serves as Advisor to the Dana-Farber Cancer Institute, as part of its Business Development Council. Luba is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst, Founder of the Pharma Digital Health Roundtable, and a Lecturer at Boston University Law School and School of Management where she has taught courses in life sciences, business law, innovation, and entrepreneurship since 2014. Luba’s career has spanned leadership roles in venture investing, business development, Mergers & Acquisitions, law, and operations, previously serving as Venture Partner at Colt Ventures, leading BD and Strategy for Axcella Health, a Flagship Ventures company, and serving as Senior Mergers & Acquisitions Counsel at Pfizer Inc. Luba began her career practicing law at a leading national law firm, Wilmer Cutler Pickering Hale and Dorr, where she represented clients in securities, IP, regulatory, corporate, and litigation matters. Luba is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology. Luba served as a non-profit board member of Longwood Symphony Orchestra, executive coach for MassNextGen, co-chair of MassBio’s Entrepreneur’s University, and mentor and judge for MassCONNECT, MIT 100K Entrepreneurship Competition, and MassChallenge.

Matteo Lai is co-founder and CEO of Empatica, an AI and medical devices company based in Cambridge, Massachusetts and Milan, Italy. Empatica has developed Embrace, the world’s smallest and most accurate wearable sensor suite for research, and become the world’s first FDA cleared smart watch for use in Neurology. Matteo studied Engineering and trained as an Architect, holds a Double MSc degree in Architecture and a Master in Innovation Management.

Sarah Lindenauer is a Product & Portfolio Manager within the Innovation and Digital Health Accelerator (IDHA) at Boston Children’s Hospital. She is focused on accelerating digital health technologies through the development pipeline from inception through commercialization. She is also responsible for managing the accelerator portfolio of innovations. She enjoys working with clinicians and entrepreneurs to build and scale market-competitive technologies for patient impact. Prior to joining Boston Children’s, Sarah worked as a digital strategist for InVentiv Health, consulting to biopharmaceutical and medical device companies on the development of digital adherence and disease education programs. Before that, Sarah worked for a digital health start-up, where she developed a multi-disciplinary framework for the evaluation of third party health applications and advised product managers regarding the optimization of user experience for behavior change. Sarah received both her Master’s in Public Health and her undergraduate degree from the University of Michigan in Ann Arbor.

Nathan Treloar is President and Co-founder of Orbita. He’s a respected expert and frequent speaker on consumer and business trends in voice and conversational user experiences in healthcare, as well as search, text and data mining, content management, and knowledge management, and has advised hundreds of the world’s largest companies and government agencies on their applications. Previously, Nathan held key executive positions at FAST Search, Microsoft, RAMP, and Ektron.